Technology | Radiation Therapy | October 18, 2016

Elekta Introduces Leksell Vantage Stereotactic System for Neurosurgery

Novel head frame designed for greater patient comfort and improved clinical workflow

October 18, 2016 — Elekta introduced the Leksell Vantage Stereotactic System, its latest system for very precise neurosurgery, at the European Society for Stereotactic and Functional Neurosurgery (ESSFN) meeting, Sept. 28 – Oct. 1, in Madrid.

Based on the Leksell Stereotactic System, Leksell Vantage addresses the limitations of using metal components during stereotactic magnetic resonance (MR) and computed tomography (CT) imaging. Constructed of a novel epoxy composite, the robust, metal-free head frame design may allow for faster and better stereotactic imaging. This means higher resolution MR imaging of the brain and fewer artifacts introduced in stereotactic CT scanning.

Also important to clinicians is the new stereotactic arc, a surgical positioning device that enables a faster preparation of the sterile field. Target coordinates are easily set between the left and the right brain hemisphere in deep brain stimulation (DBS) lead placements.

Leksell Vantage’s lightweight, open face design is created to improve the patient experience. In addition to making it easier to eat or drink while the frame is on, it has the potential to reduce MR scanning times. It essentially eliminates the risk of device-related skin sensations due to temperature increase during MR scans.

Stereotactic neurosurgery is a specialty often used for DBS implantations, brain biopsies and drug deliveries to delicate brain targets, as well as cranial radiosurgery.

Leksell Vantage Stereotactic System is not yet CE marked or U.S. Food and Drug Administration (FDA) 510(k) cleared and is not available for sale or distribution. It is expected to be available for clinical use in Europe during 2017.

The Leksell Vantage head frame is designed to be compatible with Leksell Gamma Knife Icon in a future release.

For more information: www.elekta.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation